Cue Biopharma Stock Forecast - Triple Exponential Smoothing
| CUE Stock | USD 1.02 0.01 0.97% |
The Triple Exponential Smoothing forecasted value of Cue Biopharma on the next trading day is expected to be 0.99 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.51. Cue Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cue Biopharma stock prices and determine the direction of Cue Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cue Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Cue |
Cue Biopharma Triple Exponential Smoothing Price Forecast For the 24th of November
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Cue Biopharma on the next trading day is expected to be 0.99 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.02, and the sum of the absolute errors of 5.51.Please note that although there have been many attempts to predict Cue Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cue Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cue Biopharma Stock Forecast Pattern
| Backtest Cue Biopharma | Cue Biopharma Price Prediction | Buy or Sell Advice |
Cue Biopharma Forecasted Value
In the context of forecasting Cue Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cue Biopharma's downside and upside margins for the forecasting period are 0.01 and 12.92, respectively. We have considered Cue Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Cue Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Cue Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0054 |
| MAD | Mean absolute deviation | 0.0934 |
| MAPE | Mean absolute percentage error | 0.0797 |
| SAE | Sum of the absolute errors | 5.512 |
Predictive Modules for Cue Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cue Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cue Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Cue Biopharma
For every potential investor in Cue, whether a beginner or expert, Cue Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cue Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cue. Basic forecasting techniques help filter out the noise by identifying Cue Biopharma's price trends.View Cue Biopharma Related Equities
| Risk & Return | Correlation |
Cue Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cue Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cue Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cue Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Cue Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cue Biopharma shares will generate the highest return on investment. By undertsting and applying Cue Biopharma stock market strength indicators, traders can identify Cue Biopharma entry and exit signals to maximize returns.
Cue Biopharma Risk Indicators
The analysis of Cue Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cue Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cue stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.51 | |||
| Semi Deviation | 5.93 | |||
| Standard Deviation | 11.81 | |||
| Variance | 139.43 | |||
| Downside Variance | 44.14 | |||
| Semi Variance | 35.18 | |||
| Expected Short fall | (12.72) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cue Biopharma is a strong investment it is important to analyze Cue Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cue Biopharma's future performance. For an informed investment choice regarding Cue Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Cue Biopharma to cross-verify your projections. For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Biopharma. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 0.172 | Quarterly Revenue Growth 0.923 | Return On Assets (0.52) | Return On Equity (1.39) |
The market value of Cue Biopharma is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Cue Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Biopharma's market value can be influenced by many factors that don't directly affect Cue Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.